Home » Topics » Regulatory

Regulatory
RSS

Organogenesis seeks FDA approval of Apligraf for diabetic foot ulcers

Dec. 23, 1999

New use for sPLA2 inhibitor claimed by Lilly: LY-315920 for IBS

Dec. 23, 1999

FDA is first agency worldwide to approve new fluoroquinolone for marketing

Dec. 22, 1999

Dexmedetomidine receives FDA marketing approval

Dec. 22, 1999

FDA approves topical treatment for nail fungus

Dec. 21, 1999

Schwarz sells intranasal scopolamine rights to Nastech

Dec. 21, 1999

Swiss regulatory authorities grant Visudyne Therapy its first approval

Dec. 20, 1999

Seretide MDI submitted for European marketing approval

Dec. 17, 1999

Novartis files NDA for extended-release formulation of fluvastatin

Dec. 16, 1999

NIH-sponsored study fails to confirm efficacy of secretin in autism

Dec. 14, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...